|
|
|
|
| LEADER |
00000cam a2200000 7i4500 |
| 001 |
0000092014 |
| 005 |
20220215093000.0 |
| 008 |
170601s2016 nyu eng |
| 020 |
|
|
|a 9781493933211
|
| 020 |
|
|
|a 9781493933235
|
| 040 |
|
|
|a UniSZA
|e rda
|
| 050 |
0 |
0 |
|a QP801.A63
|b A58 2016
|
| 060 |
1 |
0 |
|a QV 350
|b .A629 2016
|
| 090 |
0 |
0 |
|a QP801.A63
|b A58 2016
|
| 245 |
0 |
0 |
|a Antibiotic pharmacodynamics
|c edited by John C. Rotschafer, David R. Andes, Keith A. Rodvold
|
| 264 |
|
1 |
|a New York :
|b Humana Press
|c c2016
|
| 300 |
|
|
|a xi, 666 pages :
|b illustration ;
|c 26 cm.
|
| 336 |
|
|
|a text
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|2 rdamedia
|
| 338 |
|
|
|a volume
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index
|
| 505 |
0 |
|
|a 1. General concepts of pharmacodynamics for anti-infective agents -- 2. In vitro pharmacodynamic models to evaluate anti-infective pharmacodynamics -- 3. Animal models to evaluate anti-infective pharmacodynamics -- 4. Pharmacodynamic issues in antibiotic combinations -- 5. Methodologies for protein binding determination in anti-infective agents -- 6. Evaluation of exposure-response relationships using clinical data: basic concepts and applications -- 7. Toxicokinetics and toxicodynamics of antiinfective agents -- 8. Pharmacodynamics of fluoroquinolones -- 9. Aminoglycoside pharmacodynamics -- 10. Polymyxin pharmacokinetics and pharmacodynamics -- 11. Vancomycin pharmacodynamics: optimal vs. controversial -- 12. Pharmacodynamics of lipoglycopeptides -- 13. Pharmacodynamics of daptomycin -- 14. Pharmacodynamics of macrolides, azalides, and ketolides -- 15. Antifungal pharmacokinetics and pharmacodynamics -- 16. Pharmacokinetics and pharmacodynamics of the tuberculosis drugs -- 17. Pharmacodynamics of antimalarial agents -- 18. Pharmacodynamics of antiviral agents -- 19. Pharmacodynamics of antiretroviral agents -- 20. Implementing a continuous or prolonged infusion beta-lactam program in the hospital setting -- 21. Pharmacodynamic considerations in critically Ill patients -- 22. Pharmacodynamic considerations and special populations: pediatrics -- 23. Pharmacodynamics and obesity -- 24. Drug development process and regulatory science -- 25. Antibiotic stewardship and applications of pharmacodynamics
|
| 650 |
|
0 |
|a Antibiotics
|x Physiological effect
|
| 650 |
|
0 |
|a Drugs
|x Physiological effect
|
| 650 |
1 |
2 |
|a Anti-Bacterial Agents
|x pharmacology
|
| 650 |
2 |
2 |
|a Models, Biological
|
| 700 |
1 |
|
|a Andes, David R. ,
|e author
|
| 700 |
1 |
|
|a Rodvold, Keith ,
|e author
|
| 700 |
1 |
|
|a Rotschafer, John C. ,
|e author
|
| 999 |
|
|
|a 1000169265
|b Book
|c OPEN SHELF (30 DAYS)
|e Tembila Campus
|